Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Assistant Professor Jordan King

University of Utah, Salt Lake City (United States of America)

13 More presentations in this session

Presentation thumbnail

A technological approach to improving efficiency of primary to secondary care referrals

Doctor J. Graby (Bristol, GB)

Abstract Slides

Presentation thumbnail

An observational, international, cohort study to evaluate the satisfaction and preferences of patients in preventive treatment of secondary cardiovascular events with a cardiovascular polypill

Doctor J. Cosin Sales (Valencia, ES)

Abstract Slides

Presentation thumbnail

Continued financial benefits of LATIN telemedicine program from avoiding unnecessary transfer of patients

Doctor M. Torres (Poughkeepsie, US)

Abstract Slides

Presentation thumbnail

Rate, cause and costs of Heart Failure hospitalizations following ICD/CRT-D replacement: preliminary data from an Italian multicenter registry

Doctor F. Zanon (Rovigo, IT)

Presentation thumbnail

The cost of pacemaker complications

Doctor C. Brough (Cheshire, GB)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 6 - Health economics and policy

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study

Congress Presentation

The cost-effectiveness of a digitally enabled telerehabilitation program delivered nationally to patients in Australia

Congress Presentation

Let’s go digital: implementing cardiac rehabilitation - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources